Fucoidan inhibits EGFR redistribution and potentiates sorafenib to overcome sorafenib-resistant hepatocellular carcinoma

Luo, JL; Li, L; Zhu, ZYM; Chang, B; Deng, F; Wang, D; Lu, X; Zuo, DM; Chen, QY; Zhou, J

Zhou, J (通讯作者)，Southern Med Univ, Sch Basic Med Sci, Dept Immunol, Guangzhou, Guangdong, Peoples R China.;Chen, QY (通讯作者)，Guangdong Prov Peoples Hosp, Med Res Inst, Guangdong Acad Med Sci, Guangzhou, Guangdong, Peoples R China.;Zhou, J (通讯作者)，Key Lab Funct Prote Guangdong Prov, Guangzhou, Guangdong, Peoples R China.

BIOMEDICINE & PHARMACOTHERAPY, 2022; 154 ():

Abstract

Hepatocellular carcinoma (HCC) is one of the leading causes of cancer-related deaths worldwide. Although sorafenib is a standard first-line molecule-t......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索